Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Foot

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Accounts of Chemical Research|November 16, 2005
Tandem oxidation processes using manganese dioxide: discovery, applications, and current studiesRichard J K Taylor, Mark Reid, Jonathan Foot, et al.
British Journal of Pharmacology|April 25, 2017
Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammationSerena Becchi, Alberto Buson, Jonathan Foot, et al.
Nature Communications|April 10, 2025
Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory diseaseElias Glaros, Jonathan Foot, Ben Rayner, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in <i>mdx</i> MiceFrancesca Gasparella, Leonardo Nogara, Elena Germinario, et al.
Scientific Reports|July 2, 2025
The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagementLara Perryman, Alison Findlay, Jana Baskar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Accounts of Chemical Research|November 16, 2005
Tandem oxidation processes using manganese dioxide: discovery, applications, and current studiesRichard J K Taylor, Mark Reid, Jonathan Foot, et al.
British Journal of Pharmacology|April 25, 2017
Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammationSerena Becchi, Alberto Buson, Jonathan Foot, et al.
Nature Communications|April 10, 2025
Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory diseaseElias Glaros, Jonathan Foot, Ben Rayner, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in <i>mdx</i> MiceFrancesca Gasparella, Leonardo Nogara, Elena Germinario, et al.
Scientific Reports|July 2, 2025
The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagementLara Perryman, Alison Findlay, Jana Baskar, et al.
Pageof 1